Antioxidant effects of natural bioactive compounds

Current Pharmaceutical Design

Volumn 15, Issue 26, 2009, Pages 3063-3073

  Balsano, Clara ^a   Alisi, Anna ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Antioxidants; Oxidative stress; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; BRASSICA EXTRACT; CAROTENOID; CYSTEINE; DIHYDROLIPOATE; FLAVONOID; GLUCOSINOLATE; IMMUNOMODULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; RESVERATROL; SELENIUM; THIOCTIC ACID; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BROCCOLI; BRUSSELS SPROUT; CABBAGE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CAULIFLOWER; CELL CYCLE ARREST; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CYTOTOXICITY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DRUG MEGADOSE; DRUG STRUCTURE; FOOD INTAKE; FRUIT; HEALTH PROMOTION; HUMAN; HYDROPHILICITY; INNATE IMMUNITY; LIPID PEROXIDATION; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; ORGANISM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SIGNAL TRANSDUCTION; STOMACH CANCER; VEGETABLE;

ANIMALS; ANTIOXIDANTS; FRUIT; HUMANS; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; VEGETABLES;

EID: 70449431360     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209789058084     Document Type: Review

References (129)

1. Cadenas E. Biochemistry of oxygen toxicity. Annu Rev Biochem 1989; 58: 79-110.
2. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004; 266: 37-56. (Pubitemid 39562306)
3. Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. Oxidative stress and cell signalling. Curr Med Chem 2004; 11: 1163-1182.
4. Limón-Pacheco J, Gonsebatt ME. The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat Res 2009; 674(1-2): 137-147
5. Benz CC, Yau C. Ageing, oxidative stress and cancer: paradigms in parallax. Nat Rev Cancer 2008; 8: 875-879
6. Muller M. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal 2009; 11: 59-98.
7. Fatokun AA, Stone TW, Smith RA. Oxidative stress in neurodegeneration and available means of protection. Front Biosci 2008; 13: 3288-3311 (Pubitemid 351594683)
8. Bruckdorfer KR. Antioxidants and CVD. Proc Nutr Soc 2008; 67: 214-222
9. Khan N, Afaq F, Mukhtar H. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal 2008; 10: 475-510.
10. Loschen G, Flohe B. Chance respiratory chain linked H2O2 production in pigeon heart mitochondria. FEBS Lett 1971; 18: 261-263
11. Inoue M, Sato EF, Nishikawa M, Park AM, Kira Y, Imada I, et al. Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr Med Chem 2003; 10: 2495-2505 (Pubitemid 37460972)
12. V Cadenas E, Davies KJA. Mitochondrial free radical generation, oxidative stress, and aging. Free Rad Biol Med 2000; 29: 222-230 (Pubitemid 30734905)
13. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia- reoxygenation injury. Am J Physiol Cell Physiol 2002; 282: C227-41. (Pubitemid 34663181)
14. Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition 1996; 12: 274-277
15. Schrader M, Fahimi HD. Peroxisomes and oxidative stress. Biochim Biophys Acta 2006; 1763(12): 1755-1766
16. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39(1): 44-84. (Pubitemid 44566469)
17. Suliman HB, Welty-Wolf KE, Carraway M, Tatro L, Piantadosi CA. Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc Res 2004; 64: 279-288 (Pubitemid 39361689)
18. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996; 10: 709-720 (Pubitemid 26172817)
19. Ji LL, Leeuwenburgh C, Leichtweis S, Gore M, Fiebig R, Hollander J, et al. Oxidative stress and aging. Role of exercise and its influences on antioxidant systems. Ann N Y Acad Sci 1998; 854: 102-117
20. Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002; 192: 1-15.
21. Chuang YY, Chen Y, Gadisetti Chandramouli VR, Coffin D, Tsai MH, DeGraff W. et al. Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res 2002; 62: 6246-6254 (Pubitemid 35244478)
22. Torres M, Forman HJ. Redox signaling and the MAP kinase pathways. Biofactors 2003; 17: 287-292 (Pubitemid 37267162)
23. Gius D, Botero A, Shah S, Curry HA. Intracellular oxidation/ reduction status in the regulation of transcription factors NF-kappaB and AP-1. Toxicol Lett 1999; 106: 93-106. (Pubitemid 29257819)
24. Hirota K, Matsui M, Murata M, Takashima Y, Cheng FS, Itoh T, et al. Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochem Biophys Res Commun 2000; 274: 177-182. (Pubitemid 30496776)
25. Wei SJ, Botero A, Hirota K, Bradbury CM, Markovina S, Laszlo A, et al. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res 2000; 60: 6688-6695
26. Karimpour S, Lou J, Lin LL, Rene LM, Lagunas L, Ma X, et al. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene 2002; 21: 6317-6327
27. Mustacich D, Powis G. Thioredoxin reductase. Biochem J 2000; 346: 1-8.
28. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, et al. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A twostep mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem 1999; 274: 27891-27897 (Pubitemid 129527845)
29. Xanthoudakis S, Miao G, Wang F, Pan YC, Curran T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J 1992; 11: 3323-3335
30. Bogdan C, Rollinghoff M, Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 2000; 12: 64-76. (Pubitemid 30093452)
31. Rada B, Leto TL. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib Microbiol 2008; 15: 164-187
32. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79: 170-200. (Pubitemid 30327531)
33. De Forge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, Remick DG. Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem 1993; 268: 25568-25576 (Pubitemid 23358166)
34. Legrand-Poels S, Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006; 72: 1493-1505 (Pubitemid 44666727)
35. Yoshida Y, Maruyama M, Fujita T, Arai N, Hayashi R, Araya J, et al. Reactive oxygen intermediates stimulate interleukin-6 production in human bronchial epithelial cells. Am J Physiol 1999; 276: L900-8.
36. Hsu HY, Wen MH. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 2002; 277: 22131-22139
37. Tripathi P, Hildeman D. Sensitization of T cells to apoptosis - a role for ROS? Apoptosis 2004; 9: 515-523
38. Larbi A, Kempf J, Pawelec G. Oxidative stress modulation and T cell activation. Exp Gerontol 2007; 42: 852-858 (Pubitemid 47268736)
39. Seifried HE, Anderson DE, Fisher EI, Milner JA. A review of the interaction among dietary antioxidants and reactive oxygen species J Nutr Biochem 2007; 18: 567-579
40. Mates JM, Perez-Gomez C, De Castro IN. Antioxidant enzymes and human diseases. Clin Biochem 1999; 32: 595-603.
41. McCall MR, Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med 1999; 26: 1034-1053
42. Sies H, Stahl W, Sevanian A. Nutritional, dietary and postprandial oxidative stress. J Nutr 2005; 135: 969-972 (Pubitemid 40638292)
43. Behrend L, Henderson G, Zwacka RM. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 2003; 31: 1441-1444 (Pubitemid 38030996)
44. Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005; 10: 1881-1896 (Pubitemid 40529044)
45. Nishikawa M. Reactive oxygen species in tumor metastasis. Cancer Lett 2008; 266: 53-59
46. Wang J, Yi J. Cancer cell killing via ROS: To increase or decrease, that is a question. Cancer Biol Ther 2008; 7(12).
47. Sullivan GW, Sarembock IJ, Linden J. The role of inflammation in vascular diseases. J Leukoc Biol 2000; 67: 591-602.
48. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 29-38.
49. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004; 122: 339-352 (Pubitemid 39506592)
50. Kaliora AC, Dedoussis GV, Schmidt H. Dietary antioxidants in preventing atherogenesis. Atherosclerosis 2006; 187: 1-17.
51. Szajdek A, Borowska EJ. Bioactive compounds and health-promoting properties of berry fruits: a review. Plant Foods Hum Nutr 2008; 63: 147-156
52. Yang CS, Lambert JD, Sang S. Antioxidative and anti-carcinogenic activities of tea polyphenols. Arch Toxicol 2009; 83(1): 11-21.
53. Loft S, Møller P, Cooke MS, Rozalski R, Olinski R. Antioxidant vitamins and cancer risk: is oxidative damage to DNA a relevant biomarker? Eur J Nutr 2008; 47 (Suppl 2): 19-28.
54. Rice Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996; 20: 933-956. (Pubitemid 26157509)
55. Potter JD, Steinmetz K. Vegetables, fruit and phytoestrogens as preventive agents. IARC Sci Publ 1996; (139): 61-90.
56. Holst B, Williamson G. Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants. Curr Opin Biotechnol 2008; 19: 73-82.
57. Kojo S. Vitamin C. basic metabolism and its function as an index of oxidative stress. Curr Med Chem 2004; 11: 1041-1064 (Pubitemid 38425930)
58. Carr A, Frei B. Does Vitamin C act as a pro-oxidant under physiological conditions? FASEB J 1999; 13: 1007-1024
59. Kasparova S, Brezova V, Valko M, Horecky J, Mlynarik V, Liptaj T, et al. Study of the oxidative stress in a rat model of chronic brain hypoperfusion. Neurochem Int 2005; 46: 601-611 (Pubitemid 40614863)
60. Cuzzocrea S, Thiemermann C, Salvemini D. Potential therapeutic effect of antioxidant therapy in shock and inflammation. Curr Med Chem 2004; 11: 1147-1162 (Pubitemid 38585059)
61. Retsky KL, Chen K, Zeind J, Frei B. Inhibition of copperinduced LDL oxidation by Vitamin C is associated with decreased copper-binding to LDL and 2-oxo-histidine formation. Free Radic Biol Med 1999; 26: 90-98 (Pubitemid 29001496)
62. Cameron E, Pauling L. Supplemental ascorbate in supportive treatment of cancer-prolongation of survival times in terminal human cancer. Part 1. Proc Natl Acad Sci USA 1976; 73: 3685-3689
63. You WC, Zhang L, Gail MH, Chang YS, Liu WD, Ma JL, et al. Gastric cancer: Helicobacter pylori, serum Vitamin C, and other risk factors. J Natl Cancer Inst 2000; 92: 1607-1612
64. Knekt P, Jarvinen R, Seppanen R, Rissanen A, Aromaa A, Heinonen OP, et al. Dietary antioxidants and the risk of lung-cancer. Am J Epidemiol 1991; 134: 471-479
65. Kang SA, Jang YJ, Park H. In vivo dual effects of Vitamin C on paraquat-induced lung damage: dependence on released metals from the damaged tissue. Free Radic Res 1998; 28: 93-107.
66. Lee SH, Oe T, Blair IA. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 2001; 292: 2083-2086 (Pubitemid 32691576)
67. Suh J, Zhu BZ, Frei B. Ascorbate does not act as a pro-oxidant towards lipids and proteins in human plasma exposed to redoxactive transition metal ions and hydrogen peroxide. Free Radic Biol Med 2003; 34: 1306-1314 (Pubitemid 36519181)
68. Smith MA, Harris PLR, Sayre LM, Beckman JS, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997; 17: 2653-2657 (Pubitemid 27154998)
69. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 1998; 392: 559.
70. Catani MV, Rossi A, Costanzo A, Sabatini S, Levrero M, Melino G, et al. Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage. Biochem J 2001; 356(Pt 1): 77-85.
71. Burton GW, Ingold KU. Vitamin E as an in vitro and in vivo antioxidant. Ann NY Acad Sci 1989; 570: 7-22.
72. Atkinson J, Epand RF, Epand RM. Tocopherols and tocotrienols in membranes: a critical review. Free Radic Biol Med 2008; 44: 739-764
73. Pryor WA. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000; 28: 141-164 (Pubitemid 30045582)
74. White E, Shannon JS, Patterson RE. Relationship between vitamin E and calcium supplement use and colon cancer. Cancer Epidemiol Biomark Prev 1997; 6: 769-774 (Pubitemid 27435473)
75. Nargi JL, Ratan RR, Griffin DE. p53-independent inhibition of proliferation and p21(WAF1/Cip1)-modulated induction of cell death by the antioxidants N-acetylcysteine and vitamin E. Neoplasia 1999; 1: 544-556
76. Greenberg ER, Baron JA, Tosteson TD, Freeman DH, Beck GJ, Bond JH. Clinical-trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994; 331: 141-147
77. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer 1996; 32A: 30-38 (Pubitemid 26086324)
78. Rao AV, Rao LG. Carotenoids and human health. Pharmacol Res 2007; 55: 207-216
79. Gallicchio L, Boyd K, Matanoski G, Tao XG, Chen L, Lam TK, et al. Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr 2008; 88: 372-383
80. Young CY, Yuan HQ, He ML, Zhang JY. Carotenoids and prostate cancer risk. Mini Rev Med Chem 2008; 8: 529-537
81. Mortensen A, Skibsted LH, Truscott TG. The interaction of dietary carotenoids with radical species. Arch Biochem Biophys 2001; 385: 13-19. (Pubitemid 32988977)
82. El-Agamey A, Lowe GM, McGarvey DJ, Mortensen A, Phillip DM, Truscott TG. Carotenoid radical chemistry and antioxidant/ pro-oxidant properties. Arch Biochem Biophys 2004; 430: 37-48. (Pubitemid 39119778)
83. Burton GW, Ingold KU. Beta-carotene - an unusual type of lipid antioxidant. Science 1984; 224: 569-573
84. ATBC trial. Cigarette Smoke or Alcohol Consumption May Enhance adverse Effects of Beta Carotene in Vitamin Prevention Trials. National Institute of Health: National Cancer Institute 1996.
85. Rice-Evans CA, Sampson J, Bramley PM, Holloway DE. Why do we expect carotenoids to be antioxidants in vivo? Free Radic Res 1997; 26: 381-398
86. Kennedy TA, Liebler DE. Peroxyl radical scavenging by betacarotene in lipid bilayers-effect of oxygen partial-pressure. J Biol Chem 1992; 267: 4658-4663
87. Niles RM. Signaling pathways in retinoid chemoprevention and treatment of cancer. Mutat Res 2004; 555(1-2): 81-96.
88. Sharoni Y, Danilenko M, Dubi N, Ben-Dor A, Levy J. Carotenoids and transcription. Arch Biochem Biophys 2004; 430: 89-96.
89. Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A et al. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer Int J 2000; 36: 101-111 (Pubitemid 30317841)
90. Rice-Evans C. Flavonoid antioxidants. Curr Med Chem 2001; 8: 797-807.
91. Schroeter H, Boyd C, Spencer JPE, Williams RJ, Cadenas E, Rice- Evans C. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging 2002; 23: 861-880. (Pubitemid 35217712)
92. Polovka M, Brezova V, Stasko A. Antioxidant properties of tea investigated by EPR spectroscopy. Biophys Chem 2003; 106: 39-56. (Pubitemid 37152521)
93. Damianaki A, Bakogeorgou E, Kampa M, Notas G, Hatzoglou A, Panagiotou S et al. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem 2000; 78: 429-441 (Pubitemid 30491071)
94. Perez-Vizcaino F, Duarte J, Andriantsitohaina R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic Res 2006; 40: 1054-1065 (Pubitemid 44480546)
95. Galati G, O'Brien PJ. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anti-cancer properties. Free Radic Biol Med 2004; 37: 287-303. (Pubitemid 38833996)
96. Holst B, Williamson G. A critical review of the bioavailability of glucosinolates and related compounds. Nat Prod Rep 2004; 21: 425-447 (Pubitemid 38865722)
97. Grubb CD, Abel S. Glucosinolate metabolism and its control. Trends Plant Sci 2006; 11: 89-100.
98. Lund E. Non-nutritive bioactive constituents of plants: dietary sources and health benefits of glucosinates. Int J Vitam Nutr Res 2003; 73: 135-143 (Pubitemid 36427781)
99. Halkier BA, Gershenzon J. Biology and biochemistry of Glucosinolates. Annu Rev Plant Biol. 2006; 57: 303-333
100. Hayes JD, Kelleher MO, Eggleston IM. The cancer chemopreventive actions of phytochemicals derived from Glucosinolates. Eur J Nutr 2008; 47 (Suppl 2): 73-88.
101. Smith TK, Lund EK, Clarke RG, Bennett RN, Johnson IT. Effects of Brussels sprout juice on the cell cycle and adhesion of human colorectal carcinoma cells (HT29) in vitro. J Agr Food Chem 2005; 53: 3895-3901
102. Lynn A, Collins A, Fuller Z, Hillman K, Ratcliffe B. Cruciferous vegetables and colo-rectal cancer. Proc Nutr Soc 2006; 65: 135-144
103. Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem 2004; 11: 1135-1146 (Pubitemid 38585058)
104. Packer L, Suzuki YJ. Vitamin-E and alpha-lipoate - role in antioxidant recycling and activation of the NF-kappa B transcription factor. Mol Aspects Med 1993; 14: 229-239 (Pubitemid 23300019)
105. Ramakrishnan N, Wolfe WW, Catravas GN. Radioprotection of hematopoietic tissues in mice by lipoic acid. Radic Res 1992; 130: 360-365
106. Bustamante J, Lodge JK, Marcocci L, Tritschler HJ, Packer L, Rihn BH. Alpha-lipoic acid in liver metabolism and disease. Free Radic Biol Med 1998; 24: 1023-1039 (Pubitemid 28186244)
107. de la Lastra CA, Villegas I. Resveratrol as an antioxidant and prooxidant agent: mechanisms and clinical implications. Biochem Soc Trans 2007; 35(Pt 5): 1156-1160 (Pubitemid 350206449)
108. Das S, Das DK. Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Patents Cardiovasc Drug Discov 2007; 2: 133-138 (Pubitemid 46957321)
109. Shankar S, Singh G, Srivastava RK. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci 2007; 12: 4839-4854
110. Pirola L, Fröjdö S. Resveratrol: one molecule, many targets. IUBMB Life 2008; 60: 323-332
111. Leonard S, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, et al. Resveratrol scavenges reactive oxygen species and effects radical- induced cellular responses. Biochem Biophys Res Commun 2003; 309: 1017-1026 (Pubitemid 37122632)
112. Das DK, Maulik N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interven 2006; 6: 36-47. (Pubitemid 43327521)
113. Olas B, Wachowicz B, Bald E, Glowacki R. The protective effects of resveratrol against changes in blood platelet thiols induced by platinum compounds. J Physiol Pharmacol 2004; 55: 467-476 (Pubitemid 38901976)
114. Yen GC, Duh PD, Lin CW. Effects of resveratrol and 4- hexylresorcicol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. Free Radic Res 2003; 37: 509-514
115. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, et al. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 2007; 224: 274-283 (Pubitemid 47575677)
116. Schrauzer GN. Anticarcinogenic effects of selenium. Cell Mol Life Sci 2000; 57: 1864-1873
117. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996; 276: 1957-1963
118. Sinha R, El-Bayoumy K. Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds. Curr Cancer Drug Targets 2004; 4: 13-28. (Pubitemid 38332561)
119. Combs GF. Status of selenium in prostate cancer prevention. Br J Cancer 2004; 91: 195-199 (Pubitemid 39037057)
120. Zhong W, Oberley TD. Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res 2001; 61: 7071-7078 (Pubitemid 32946498)
121. Zhao R, Domann FE, Zhong W. Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells. Mol Cancer Ther 2006; 5: 3275-3284 (Pubitemid 46092071)
122. Ip C, Ganther HE. Relationship between the chemical forms of selenium and anticarcinogenic activity. In: Wattenberg L, Lipkin M, Boone CW, Kelloff GJ Eds, Cancer Chemoprevention. Boca Raton, FL: CRC Press 1992; pp. 479-488
123. Abdulah R, Miyazaki K, Nakazawa M, Koyama H. Chemical forms of selenium for cancer prevention. J Trace Elem Med Biol 2005; 19: 141-150 (Pubitemid 41606711)
124. Jung U, Zheng X, Yoon SO, Chung AS. Se-methylselenocysteine induces apoptosis mediated by reactive oxygen species in HL-60 cells. Free Radic Biol Med 2001; 31: 479-489 (Pubitemid 32728435)
125. Kim TS, Yun BY, Kim IY. Induction of the mitochondrial permeability transition by selenium compounds mediated by oxidation of the protein thiol groups and generation of the superoxide. Biochem Pharmacol 2003; 66: 2301-2311
126. Makropoulos V, Bruning T, Schulze-Osthoff K. Selenium mediated inhibition of transcription factor NF-kappa B and HIV-1 LTR promoter activity. Arch Toxicol 1996; 70: 277-283 (Pubitemid 126437713)
127. Mimica-Dukic N, Bozin B. Mentha L. species (Lamiaceae) as promising sources of bioactive secondary metabolites. Curr Pharm Des 2008; 14(29): 3141-3150
128. Pulitano C, Aldrighetti L. The protective role of steroids in ischemia- reperfusion injury of the liver. Curr Pharm Des 2008; 14(5): 496-503.
129. Vinsova J, Vavrikova E. Recent advances in drugs and prodrugs design of chitosan. Curr Pharm Des 2008; 14(13): 1311-1326 (Pubitemid 351997825)